Neuropsychiatric outcomes after montelukast versus inhaled corticosteroids in pediatric asthma: a pooled birth cohort study

CONCLUSIONS: Among children newly diagnosed with asthma, use of montelukast is associated with increased risks of ADHD and oppositional defiant and conduct disorders compared to ICS; among those with newly diagnosed controlled, partly controlled, or non-severe asthma, use of montelukast is associated with an increased risk of sleep disorders compared to ICS.

via https://pubmed.ncbi.nlm.nih.gov/42823762/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1lqZ3NPYysePVKsoyz66mDSgu4veDGJwnUBS47TBQPoOuNZY5J&fc=None&ff=20261011011005&v=2.20.1